Drug intelligence / Profile preview

miR-23b

Development stage
Preclinical
Lead developer
Mayo Clinic
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Subcutaneous
01

Overview

miR-23b is a microRNA that functions as a tumor suppressor by post-transcriptionally regulating genes involved in cell motility and survival. In the context of glioblastoma, miR-23b is frequently down-regulated, and its restoration has been shown to inhibit glioma cell migration and invasion. This effect is primarily mediated through the direct targeting of the 3' untranslated region (UTR) of the Pyk2 (PTK2B) mRNA, a non-receptor tyrosine kinase critical for cytoskeletal reorganization. Beyond its role in oncology, miR-23b is also involved in modulating inflammatory pathways and has been investigated for its potential in treating autoimmune conditions by targeting pathways such as NF-κB.

Other names
microRNA-23bmicroRNA23bmicroRNA 23bmiRNA-23bmiRNA23bmiRNA 23b
02

Targets

PTK2BCCNG1 (Cyclin G1 mRNA)

Beyond the preview

Go deeper on miR-23b.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-23b.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call